by Talk Business & Politics staff (staff2@talkbusiness.net) January 21, 2022 10:54 am
A newly released study indicated that childhood peanut allergies could be desensitized with oral immunotherapy treatments, and some children could achieve remission.
The clinical trial was co-led by Arkansas Children’s Research Institute (ACRI) and UAMS researcher Stacie Jones, M.D. The results were published Jan. 21 in the medical journal The Lancet.
The youngest trial participants and those who started with lower levels of peanut-specific antibodies were the most likely to be successful.
